Cite
APA Citation
Pinato, D. J., Urus, H., Newsom-Davis, T., Du Parcq, P., Belessiotis, K., Mapara, L., Gupta, N., Power, D., Weir, J., Wong, C. N., Ratnakumaran, R. P., Dominy, K., Khorashad, J., & Bower, M. (n.d.). applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy. Journal of immunotherapy, 43(2), . http://access.bl.uk/ark:/81055/vdc_100133184886.0x000013